We are live on ! Find out more
TECX

Tectonic Therapeutic

92 hedge funds and large institutions have $135M invested in Tectonic Therapeutic in 2021 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 43 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

14,200% more call options, than puts

Call options by funds: $572K | Put options by funds: $4K

1% more ownership

Funds ownership: 5.7%6.7% (+1%)

7% less funds holding

Funds holding: 9992 (-7)

19% less capital invested

Capital invested by funds: $166M → $135M (-$31M)

30% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 23

44% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 43

Holders
92
Holders Change
-7
Holders Change %
-7.07%
% of All Funds
1.42%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
16
Increased
24
Reduced
43
Closed
23
Calls
$572K
Puts
$4K
Net Calls
+$568K
Net Calls Change
+$594K

TECX Hedge Fund Activity: Q4 2021 in Review

92 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q4 2021, worth a combined $135M — down 19% from $166M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of TECX and 16 opened new positions — a net loss of 7 holders — while 43 trimmed existing stakes and 24 added.

The largest buyer was Goldman Sachs, adding an estimated $4.55M. The largest seller was Camber Capital Management, cutting an estimated $7.18M.

  • 92 institutional investors held Tectonic Therapeutic (TECX) as of Q4 2021, down from 99 in Q3 2021.
  • Funds reported $135M of Tectonic Therapeutic stock for Q4 2021, down 19% quarter-over-quarter.
  • 16 funds opened new Tectonic Therapeutic positions in Q4 2021 and 23 closed out, a net change of -7 holders.
  • The largest Tectonic Therapeutic buyer in Q4 2021 was Goldman Sachs, an estimated $4.55M added.
  • The largest Tectonic Therapeutic seller in Q4 2021 was Camber Capital Management, an estimated $7.18M sold.

Based on aggregated 13F filings for Q4 2021.